Efficacy News and Research

RSS
Cordis enrolls first patient in the CYPRESS clinical study

Cordis enrolls first patient in the CYPRESS clinical study

Cannabis Science enters into an agreement with Leading Points to represent its products to various government and military agencies

Cannabis Science enters into an agreement with Leading Points to represent its products to various government and military agencies

BloodStor biopreservation media product platform for cord blood banking industry

BloodStor biopreservation media product platform for cord blood banking industry

Results of the Phase II SEPIA-ACS1/ TIMI-42 study presented at the plenary session of the Annual European Society of Cardiology

Results of the Phase II SEPIA-ACS1/ TIMI-42 study presented at the plenary session of the Annual European Society of Cardiology

FDA approves the usage of Valcyte for preventing CMV disease in pediatric patients

FDA approves the usage of Valcyte for preventing CMV disease in pediatric patients

RE-LY trial establishes effectiveness of PRADAX in reducing stroke risk in AF patients

RE-LY trial establishes effectiveness of PRADAX in reducing stroke risk in AF patients

Oral dabigatran etexilate reduces the risk of stroke and systemic embolism

Oral dabigatran etexilate reduces the risk of stroke and systemic embolism

Intermediate dosages of otamixaban reduce acute coronary complications

Intermediate dosages of otamixaban reduce acute coronary complications

Initial results of the CURRENT-OASIS 7 clinical trial due for release

Initial results of the CURRENT-OASIS 7 clinical trial due for release

Phase 2B clinical trial results of oral vernakalant to be presented at the ESC Congress 2009

Phase 2B clinical trial results of oral vernakalant to be presented at the ESC Congress 2009

Two human biomarker assays that play a key role in the early detection of kidney damage provide assistance in drug development

Two human biomarker assays that play a key role in the early detection of kidney damage provide assistance in drug development

Facet Biotech And Trubion to jointly develop and commercialize the TRU-016 SMIP protein therapeutic

Facet Biotech And Trubion to jointly develop and commercialize the TRU-016 SMIP protein therapeutic

Boston Scientific to discuss final results of MADIT-CRT trial at the European Society of Cardiology Congress

Boston Scientific to discuss final results of MADIT-CRT trial at the European Society of Cardiology Congress

Thrombogenics issues business update and half year results

Thrombogenics issues business update and half year results

Milestone reached in Biotie Wyeth collaboration for the development of PDE10 inhibitors for schizophrenia

Milestone reached in Biotie Wyeth collaboration for the development of PDE10 inhibitors for schizophrenia

NAT gains importance as traditional testing methods become inadequate

NAT gains importance as traditional testing methods become inadequate

Opinion piece outlines new model for foreign aid

Opinion piece outlines new model for foreign aid

Elorac offers Zithranol-RR for treating plaque psoriasis

Elorac offers Zithranol-RR for treating plaque psoriasis

Infectious Disease Research Institute commences clinical trial of its leishmaniasis vaccine in Sudan

Infectious Disease Research Institute commences clinical trial of its leishmaniasis vaccine in Sudan

NIMH grants Xhale $1.7 million to develop the SMART medication adherence system for HIV/AIDS therapies

NIMH grants Xhale $1.7 million to develop the SMART medication adherence system for HIV/AIDS therapies

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.